Which of the following medications has no intrinsic sympathomimetic activity?

• A. Propranolol
• B. Metoprolol
• C. Atenolol
• D. Carvedilol

Answer: (A)

The correct choice is based on the pharmacological profiles of these medications. Propranolol is a non-selective beta-blocker that is well known for lacking intrinsic sympathomimetic activity. This means that it does not activate beta-adrenergic receptors while blocking them, distinguishing it from other beta-blockers that possess some partial agonist activity.

In contrast, metoprolol and atenolol are selective beta-1 adrenergic antagonists that primarily target the heart, and both are commonly used for managing hypertension and other cardiovascular conditions without significant intrinsic sympathomimetic activity. However, their profiles can vary slightly, with metoprolol exhibiting a bit of partial agonistic activity under certain conditions, although it's mostly considered to lack significant sympathomimetic properties.

Carvedilol is a non-selective beta-blocker with additional alpha-1 blocking effects and does exhibit some intrinsic sympathomimetic activity. This characteristic allows it to provide certain physiological benefits sometimes not seen with traditional beta-blockers, such as maintaining some heart rate during exercise.

Thus, when assessing medications for their sympathomimetic activity, propranolol stands out due to its clear absence of this intrinsic activity, making it a reliable choice for conditions requiring